Low or defective TAP1 in breast tumors predicts higher risks for developing metastasis [35] and down-regulation of the interferon-stimulated genes IFIT1 and MX1 has been linked to immune evasion mechanisms and tumor progression [36-39]. Here, IFIT1 is linked to breast neoplasm.